FR2510409B1 - - Google Patents

Info

Publication number
FR2510409B1
FR2510409B1 FR8213278A FR8213278A FR2510409B1 FR 2510409 B1 FR2510409 B1 FR 2510409B1 FR 8213278 A FR8213278 A FR 8213278A FR 8213278 A FR8213278 A FR 8213278A FR 2510409 B1 FR2510409 B1 FR 2510409B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8213278A
Other languages
French (fr)
Other versions
FR2510409A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of FR2510409A1 publication Critical patent/FR2510409A1/fr
Application granted granted Critical
Publication of FR2510409B1 publication Critical patent/FR2510409B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8213278A 1981-07-29 1982-07-29 Procede de purification de l'interferon Granted FR2510409A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56118865A JPS5821691A (ja) 1981-07-29 1981-07-29 α−及びβ−インタ−フェロンの精製方法

Publications (2)

Publication Number Publication Date
FR2510409A1 FR2510409A1 (fr) 1983-02-04
FR2510409B1 true FR2510409B1 (OSRAM) 1984-06-22

Family

ID=14747035

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8213278A Granted FR2510409A1 (fr) 1981-07-29 1982-07-29 Procede de purification de l'interferon

Country Status (6)

Country Link
US (1) US4465622A (OSRAM)
JP (1) JPS5821691A (OSRAM)
CA (1) CA1185178A (OSRAM)
DE (1) DE3223087C2 (OSRAM)
FR (1) FR2510409A1 (OSRAM)
GB (1) GB2111061B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
EP0150067A3 (en) * 1984-01-23 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
JPS60243028A (ja) * 1984-04-28 1985-12-03 Kyowa Hakko Kogyo Co Ltd インタ−フエロンの可溶化方法
EP0168008A3 (en) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
WO1986000531A1 (fr) * 1984-07-10 1986-01-30 Takeda Chemical Industries, Ltd. Composition a base de gamma-interferon
US4873312A (en) * 1985-04-25 1989-10-10 Amgen Method for purifying interferon and composition of matter produced thereby
DE3628468A1 (de) * 1986-08-21 1988-03-03 Thomae Gmbh Dr K Neue applikationsformen fuer (alpha)-interferone
CA2024046A1 (en) * 1989-09-28 1991-03-29 Alberto Ferro Stabilized leukocyte-interferons
ES2066934T3 (es) * 1990-01-27 1995-03-16 Roland Man Druckmasch Procedimiento y dispositivo para la medicion del contenido de alcohol en el liquido de humedecimiento en una maquina de imprimir en offset.
IT1272252B (it) * 1994-05-16 1997-06-16 Applied Research Systems Formulazioni liquide di interferone beta
US5861174A (en) 1996-07-12 1999-01-19 University Technology Corporation Temperature sensitive gel for sustained delivery of protein drugs
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6433144B1 (en) * 1999-01-12 2002-08-13 Viragen, Inc. Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
DE60139339D1 (de) * 2000-11-07 2009-09-03 Novartis Vaccines & Diagnostic Stabilisierte interferonzusammensetzungen
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
US7367961B2 (en) * 2004-09-10 2008-05-06 Depuy Spine, Inc. Intradiscal injection of autologous interferon
CN113845560A (zh) * 2020-06-28 2021-12-28 佛山汉腾生物科技有限公司 目的蛋白纯化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4810232B1 (OSRAM) * 1970-09-04 1973-04-02
FR2351665A1 (fr) * 1976-05-21 1977-12-16 Elf Aquitaine Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
NL7605805A (nl) * 1976-05-28 1977-11-30 Stichting Rega V Z W Werkwijze voor het zuiveren van interferon.

Also Published As

Publication number Publication date
US4465622A (en) 1984-08-14
DE3223087C2 (de) 1985-11-14
JPS5821691A (ja) 1983-02-08
GB2111061B (en) 1984-11-21
DE3223087A1 (de) 1983-02-17
FR2510409A1 (fr) 1983-02-04
CA1185178A (en) 1985-04-09
GB2111061A (en) 1983-06-29
JPS6254440B2 (OSRAM) 1987-11-14

Similar Documents

Publication Publication Date Title
FR2500852B1 (OSRAM)
FR2501476B1 (OSRAM)
DE3249701A1 (OSRAM)
FR2501437B1 (OSRAM)
FR2498011B1 (OSRAM)
FR2499734B1 (OSRAM)
FR2500749B1 (OSRAM)
FR2501888B1 (OSRAM)
FR2498764B1 (OSRAM)
FR2498227B1 (OSRAM)
FR2497639B1 (OSRAM)
FR2501879B1 (OSRAM)
FR2501468B3 (OSRAM)
FR2500605B3 (OSRAM)
FR2498259B1 (OSRAM)
FR2501439B1 (OSRAM)
DE3690711T1 (OSRAM)
DK73181A (OSRAM)
FR2501382B1 (OSRAM)
FR2497676B3 (OSRAM)
FR2499123B3 (OSRAM)
FR2500382B3 (OSRAM)
FR2501682B1 (OSRAM)
FR2498516B1 (OSRAM)
FR2501340B1 (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse
ST Notification of lapse